Panorama
Optimizing TV and Search in the Age of Amazon Healthcare
The U.S. is one of only two countries that allow pharma ads to run ...
Who Needs to Care about Value Frameworks?
Public scrutiny on healthcare costs, particularly drug costs, has been mounting over the past ...
What Patients Really Want from AI in Healthcare
Lately, when people ask me about artificial intelligence and healthcare, I tend to talk ...
Taking a Super Bowl Approach to Medical Conferences
A funny thing happens when you talk “convention media.” People focus on how it ...
The Trouble with Sampling in the State of Ohio
Have you ever heard about Ohio’s Terminal Distributor of Dangerous Drugs (TDDD) licenses? Before ...
Marketing Interrupted: The [Very] Broken Line of Sight from Strategy to Execution
This may come as a shock to many: The amount of time, effort, and ...
Next-Generation Forecasting Must Account for Payer Controls
The market access landscape for pharmaceutical products has shifted as payers struggle to control ...
Turning Over All the Cards on Provider/Life Sciences Collaboration
When you watch a Texas Hold’em poker tournament on TV, it’s easy to get ...
How Drug Re-innovation Can Potentially Boost Pharma’s Depleting R&D Pipeline
The pharmaceutical industry’s typical R&D model of developing new chemical entities (NCEs) and creating ...
Transforming Hub Services and Increasing Speed to Therapy
In this final installment of a three-part series on integrating comprehensive hub services and ...
Trends that Emerged from J.P. Morgan Week 2018
Every January, tens of thousands of healthcare CEOs, investors, and business development executives descend ...
Clinical Health Educator—A Key Player in a Patient-Centric Approach
Improving patients’ health is the cornerstone of treatment strategies. In this patient-centric era, a ...
Best Practices for Forging Strategic Sponsor-CRO Relationships
A true strategic partnership has benefits for both the sponsor and the contract research ...
